Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$236K Sell
13,912
-1,999
-13% -$49.2K ﹤0.01% 2262
2020
Q3
$591K Buy
15,911
+4,486
+39% +$141K ﹤0.01% 1723
2020
Q2
$260K Buy
11,425
+2,223
+24% +$47.6K ﹤0.01% 2078
2020
Q1
$81K Buy
+9,202
New +$141K ﹤0.01% 2237
2019
Q3
Sell
-612
Closed -$6K 2572
2019
Q2
$6K Buy
+612
New +$6.46K ﹤0.01% 2839

Other funds holding MESO

Aperio Group's MESO Position: Q4 2020 in Review

Aperio Group reduced its Mesoblast (MESO) stake by 13% in Q4 2020, selling an estimated $49.2K and leaving 13,912 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #2262.

Aperio Group first reported a position in MESO in Q2 2019 and has held it in 5 quarters since. The position peaked at $591K in Q3 2020. 53 funds tracked by Wall St. Rank hold MESO as of Q4 2020.

  • Aperio Group held 13,912 shares of Mesoblast worth $236K as of Q4 2020.
  • Aperio Group sold 1,999 Mesoblast shares in Q4 2020, an estimated $49.2K.
  • Mesoblast made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2262 holding.
  • Aperio Group first reported a position in Mesoblast in Q2 2019 and has held it in 5 quarters since.
  • Aperio Group's Mesoblast position peaked at $591K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held Mesoblast as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.